Abstract
The effect of 10−8 M 1,25-dihydroxyvitamin D3 [1,25 (OH)2D3] on the phosphoinositide pathway, was studied on [3H] inositol and 45Ca2+ efflux and on insulin release of islets from vitamin D-deficient rats, during an acetylcholine (Ach) stimulus in perifusion. The insulin release, which was low in vitamin D-deficient rats, was enhanced by this treatment. The 3H flux, reflecting phosphoinositide breakdown, was also increased. The 45Ca2+ flux was stimulated both during the first 14 min peak (mobilization of IP3-sensitive reticular Ca2+ stores) and during the following sustained small elevation of 45Ca2+ flux, reflecting protein kinase C (PKC) activation and consequently increased phosphorylation of Ca2+ channel proteins. These effects were larger during perifusions performed in the presence of glucose which is known to open Ca2+ channels, suggesting a synergistic influence of glucose and 1,25(OH)2D3. This positive influence of 1,25(OH)2D3 on Ca2+ entry by Ca2+ channels was confirmed by the use of nifedipine — a Ca2+ channel blocker-which suppressed the 45Ca2+ flux and lowered insulin secretion. Moreover, the sustained 45Ca2+ flux also disappeared in islets from vitamin D-deficient rats supplemented by 1,25(OH)2D3 but perifused without extracellular Ca2+, supporting the hypothesis of 1,25(OH)2D3-induced activation of PKC. Thus, 1,25(OH)2D3 may provide supplementary calcium to the B cell by regulating the intracellular signalling processes involving phospholipid metabolism, PKC induction, Ca2+ mobilization and Ca2+ entry by Ca2+ channels.
Similar content being viewed by others
References
Minghetti P.P., Norman A.W. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuity. FASEB J. 2: 3043, 1988.
Norman A., Roth J., Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors and biological response. Endocr. Rev. 3: 331,1982.
Rasmussen H., Matsumoto T., Fontaine O., Goodman D.B.P. Role of change in membrane lipid structure in the action of 1,25-dihydroxyvitamin D3. Fed Proc. 41: 72, 1982.
Nemere I., Norman A.W.. Steroid hormone actions at the plasma membrane: induced calcium uptake and exocytotic events. Mol. Cell. Endocrinol. 80: C165, 1991.
Lieberherr M., Grosse B., Duchambon P., Drucke T. A functional cell surface type receptor is required for the early action of 1,25-dihydroxyvitamin D3 on the phosphoinositide metabolism in rat enterocytes. J. Biol. Chem. 264: 20403, 1989.
Wali R.K, Baum C.L., Sitrin M.D., Brasitus T.A. 1.25(OH)2D3 vitamin-D3 stimulates membrane phosphoinositide turnover, activate protein kinase C and increases cytosolic calcium in rat colonic epithelium. J. Clin. Invest. 85: 1296, 1990.
Wali R.K., Bolt M.J.G., Tien X.-Y., Brasitus T.A., Sitrin M.D. Differential effect of 1,25-dihydroxycholecalciferol on phosphoinositide turnover in the antipodal plasma membranes of colonic epithelial cells. Biochem. Biophys. Res. Commun. 187: 1128, 1992.
De Boland A.R., Boland R.L. Rapid changes in skeletal muscle uptake induced in vitro by 1,25-dihydroxyvitamin D3 are suppressed by calcium channels blockers. Endocrinology 120: 1858, 1987.
Caffrey J.M., Farach-Carson M.C. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264: 20265, 1989.
Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Res. 13: 719, 1992.
Christakos S., Norman A.W. Studies for the mode of action of calciferol XVIII. Evidence for a specific high affinity binding protein for 1,25-dihydroxyvitamin D3 in chick kidney and pancreas. Biochem. Biophys. Res. Commun. 89: 56,1979.
Ishida H., Norman A.W. Demonstration of high affinity receptor for 1,25-dihydroxyvitamin in rat pancreas. Mol. Cell. Endocrinol. 60: 109, 1988.
Christakos S., Friedlander E.J., Frandsen B.R., Norman A.W. Studies on the mode of action of calciferol. XIII Development of a radioimmunoassay for vitamin D-dependent chick intestinal calcium binding protein and tissue distribution. Endocrinology 104: 1495, 1979.
Thomasset M., Parke CO., Cuisinier-Gleizes P. Rat calcium binding proteins: distribution, development and vitamin D dependence. Am. J. Physiol. 243: E483, 1982.
Bourlon P.M., Billaudel B., Thomasset M., Sutter B.Ch.J., Faure A Effects of vitamin D3 deficiency and repletion with 1,25-dihydroxyvitamin D3 on calbindin 28K in the rat endocrine pancreas. In: Norman A.W., Bouillon R., Thomasset, M. (Eds.), Vitamin D, Gene regulation structure Function Analysis and Clinical Application, De Gruyter, 1991, p. 627.
Cade C., Norman A.W. Rapid normalization/stimulation by 1,25 dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120: 1490, 1987.
Kadowaki S., Norman A.W. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34: 315, 1985.
Faure A., Sutter B.Ch.J., Billaudel B. Is 1,25-dihydroxyvitamin D3 the specific vitamin D3 metabolite active on insulin release and calcium handling by islets from vitamin D3-deprived rats? Diabète Metab. 17: 271, 1991.
Billaudel B., Faure A., Labriji-Mestaghanmi H., Sutter B.Ch.J. Direct in vitro effect of 1,25-dihydroxyvitamin D3 on islets insulin secretion in vitamin deficient rats: influence of vitamin D3 pretreatment. Diabète Metab. 15: 85, 1989.
Billaudel B., Faure A., Sutter B.Ch.J. Effect of 1,25-dihydroxyvitamin D3 on isolated islets from viitamin D3-deprived rats. Am. J. Physiol. 258: E643, 1990.
Billaudel B., Delbancut A., Sutter B.Ch.J., Faure, A. Stimulatory effect of 1,25-dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats. Steroids 58: 335, 1993.
Herbas T., Akalin S., Koray Z., Gedik O. Lack of effect of 1,25(OH)2D3 administration on glucose tolerance and insulin secretion in normal man. In: Norman A.W., Bouillon R. and Thomasset M. (de Gruyter) (Eds.) Vitamin D, Gene regulation Structure-Function. Analysis and Clinical Application, 1991, p.333.
Chertow B.S., Sivitz W.I., Baranetsky N.G., Clark S.A., Waite A., DeLuca H.F. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113: 1511, 1983.
Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from pancreas. Diabetes 16: 35, 1967.
Labriji-Mestaghanmi H., Billaudel B., Gamier P.E., Malaisse W.J., Sutter B.Ch.J. Vitamin D and pancreatic islet function: I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J. Endocrinol. Invest. 11: 577, 1988.
Herbert V., Lau K.S., Gottlieb C.W., Bleicher S.J. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 122: 1375, 1965.
Zawalich W.S., Diaz V.A., Zawalich K.C. Influence of cAMP and calcium on 3H inositol efflux, inositol phosphate accumulation, and insulin release from isolated rat islets. Diabetes 37: 1478, 1988.
Mathias P.C.F., Carpinelli A.R., Billaudel B., Garcia-Morales P., Valverde I., Malaisse W.J. Cholinergic stimulation of ion fluxes in pancreatic islets. Biochem. Pharmacol. 34: 3451, 1985.
Herchuelz A., Couturier E., Malaisse W.J. Regulation of calcium fluxes in pancreatic islets: glucose-induced calcium-calcium exchange. Am. J. Physiol. 238: E96, 1980.
Boschero A.C., Bordin S., Herchuelz A., Lebrun, P. Effect of glucose on 45Ca2+ outflow cytosolic Ca2+ concentration and insulin release from freshly isolated and cultured adult rat islets. Cell Calcium 11: 603, I990.
Mathias P.C.F., Best L., Malaisse W.J. Stimulation by glucose and carbamylcholine of phospholipase C in pancreatic islets. Cell Biochem. Funct. 3: 173, 1985.
Prentky M., Biden T.J. Janjic D., Irvine R.F., Berridge M.J., Wollheim C.B. Rapid mobilization of Ca2+ from rat insulinomic microsomes by inositol-1,4,5-triphosphate. Nature 309: 562, 1984.
Gylfe E. Carbachol induces sustained glucose-dependent oscillations of cytoplasmic Ca2+ in hyperpolarized pancreatic B cells. Pflügers Arch. 479: 639, 1991.
Wang J.L., Corbett J.A., Marshall C.A., McDaniel M.L. Glucose-induced insulin from purified B-cells. A role for modulation of Ca2+ influx by cAMP and protein kinase C-dependent signal transduction pathways. J. Biol. Chem. 268: 7785, 1993.
Clark R.B., Love J.T., Sgroi D., Linegenheld E., Sha’afi R. The protein kinase C inhibitor, H-7, inhibits antigen and IP-2-induced proliferation of murine T cell lines. Biochem. Biophys. Res. Commun. 145: 666, 1987.
Rajan A.S., Aguilar-Bryan L., Nelson D.A., Yaney G.C., Hsu W.K., Boyd III A.E.. Ion channels and insulin secretion. Diabetes 13: 340, 1990.
Henquin J.C., Meissner H.P. The ionic, electrical and secretory effects of endogenous cyclicadenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology 115: 1125, 1984.
Nilsson T., Arkhammar P., Halberg A., Hellman B., Berggren P.O. Extracellular Ca2+ induced a rapid increase in cytoplasmic free Ca2+ in pancreatic B-cells. Biochem. J. 248: 329, 1987.
Prentky M., Matschinsky F.M. Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanism of insulin secretion. Physiol. Rev. 67: 1185, 1987.
Hii C.S.T., Jones P.M., Persaud S.J., Howell S.L. A reassessment of the role of protein kinase C in glucose stimulated insulin secretion. Biochem. J. 246: 489, 1987.
Wollheim C.B., Siegel E.G., Sharp G.W.G. Dependency of acetylcholine-induced insulin release on Ca++ uptake by rat pancreatic islets. Endocrinology 107: 924, 1980.
Biden T.V., Prugue M.L., Davison A.G.L. Evidence for phosphatidylinositol hydrolysis in pancreatic islets stimulated with carbamoylcholine. Kinetic analysis of inositol polyphosphate metabolism. Biochem. J. 285: 541, 1992.
Rorsman P., Arkhammar P., Berggren O. Voltage activated Na+ currents and their suppression by Phorbol ester in clonal insulin-producing RINm5F cells. Am. J. Physiol. 251: C919, 1986.
Peter-Riesch B., Fathi M., Schlegel W., Wollheim C.B. Glucose and carbachol generate 1,2-diacylglycerols by different mechanisms in pancreatic islets. J. Clin. Invest. 81: 1154, 1988.
Chisholm J.C., Kirn S., Tashjian A.H. Modulation by 1,25-dihydroxycholecalciferol on the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C-1 pituitary cells. J. Clin Invest. 81: 661, 1988.
d’Embden M.C., Wark J.D. Vitamin D enhanced thyrotrophin release from rat pituitary cells: effect of Ca2+, dihydropyridines and ionomycin. J. Endocrinol. 121: 441, 1989.
Bellido T., Moreli S., Fernandez L.M., Boland R. Evidence for the participation of protein kinase-C and 3′, 5′-cyclic AMP dependent protein kinase in the stimulation of muscle cell proliferation by 1,25-dihydroxyvitamin-D3. Mol. Cell. Endocrinol. 90: 231, 1993.
Tornquist K. Pretreatment with 1,25-dihydroxycholecalciferol enhanced thyrotropin-releasing hormone-induced and inositol 1,4, 5-triphosphate-induced release of sequestered Ca2+ in permeabilized GH4C-1 pituitary cells. Endocrinology 131: 1677, 1992.
Mezzetti G., Moni M.G., Perneco Casolo L., Piccinini G., Moruzzi M.S. 1.25-dihydroxycholecalciferol-dependent calcium uptake by mouse mammary gland in culture. Endocrinology 122: 389, 1988.
Sugimoto T., Ritter C., Ried I., Morrissey J., Slatopolsky E. Effect of 1,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed parathyroid cells. Kidney Int. 33: 850, 1988.
Suzuki M., Kawaguchi Y., Momose M., Morita T., Yokohama K., Miyahara T. 1,25-dihydroxyvitamin D stimulates sodium-dependent phosphate transport by renal outer cortical brush-border membrane vesicles by directly affecting membrane fluidity. Biochem. Biophys. Res. Commun. 150: 1193,1988.
Fernandez L.M., Massheimer V., de Boland A.R. Cyclic AMP-dependent membrane proteins phosphorylation and calmodulin binding are involved in the rapid stimulation of muscle calcium uptake by 1,25-dihydroxitamin D3. Calcif. Tissue Int. 47: 314, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Billaudel, B., Bourlon, P.M.D., Sutter, B.C.J. et al. Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 18, 673–682 (1995). https://doi.org/10.1007/BF03349788
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349788